Company: NCEL
Filing Date: 2025-06-23
Form Type: F-4/A
Source: 0001213900-25-056787
Chunk: 780

Company: NewcelX Ltd.
Filing Date: 2025-06-23
Form: F-4/A
Chunk 780
---
0 |
| Expected salary increase rate |     |  2.0 |     |  2.0 |

____________ (A)The discount rate is based on high quality index -linkedcorporate bonds. Below are the reasonably possible changes as of the end of the reporting period, for each actuarial assumption, assuming that the other actuarial assumptions are constant:

| As of December 31, 2024:                                                               |     |        The change 
    in the defined 
 benefit liability 
            USD in 
         thousands |   |
|:---------------------------------------------------------------------------------------|:----|------------------:|:--|
| Sensitivity test to a change in the rate of the expected salary increase               |     |                   |   |
| The change as a result of:                                                             |     |                   |   |
| Salary increase of 1%                                                                  |     |                15 |   |
| Salary decrease of 1%                                                                  |     |               (13 | ) |
| Sensitivity test to a change in the discount rate of the plan’s assets and liabilities |     |                   |   |
| The change as a result of:                                                             |     |                   |   |
| Increase of 1% in discount rate                                                        |     |               (13 | ) |
| Decrease of 1% in discount rate                                                        |     |                15 |   |

Annex G-25 KADIMASTEM LTD.
NOTES TO FINANCIAL STATEMENTS NOTE 15: — CONVERTIBLE LOAN AND CONVERSION COMPONENT OF CONVERTIBLE LOAN AND WARRANTS A.On October 16, 2023, the Company entered into an agreement with the Alpha Capital Anstalt Fund (hereinafter, the “Alpha Fund”) and Mr. Julian Ruggieri (hereinafter, “Mr. Ruggieri”), one of the Company’s shareholders, to invest up to USD $1.7 million in the Company through a convertible loan (hereinafter, the “Loan Principal”) that may be converted into ordinary shares and non -marketablewarrants, exercisable into the Company’s ordinary shares of NIS 0.1 par value. The loan agreement was approved at the shareholders’ meeting on December 3, 2023. Below are the terms of the loan: 1.A total of USD $1.25 million (Alpha Fund — USD $1 million; Mr. Ruggieri — USD $250 thousand) (hereinafter, the “Initial Loan Amount”) will be